Dr. Lu’s research involves the use of nanoparticle-based formulations to deliver therapeutic and diagnostic agents. These are primarily applied in the diagnosis and treatment of cancer.

In this video clip, Dr. Lu talks about her project aiming to develop tumor-targeted radioactive nanoparticles that are able to treat peritoneal metastases in ovarian cancer. (Thanks for the support from American Cancer Society) (May, 2018)

Welcome to......       

News

  • The exciting collaborative work with the Physician Scientist Dr. Tulio Valdez at Stanford University has been published in Scientific Report! Free to download (August 19, 2020)
  • Congratulations to André Beringhs for receiving the prestigious Karl A. Herzog Fellowship! (May 22, 2020)
  • Check out our most recent publication in Nature Cell Biology! Glad to see that our proprietary nanoparticles containing doxorubicin exhibited the best effectiveness in inhibiting leukemic stem cells!  (April 28, 2020)
  • Check out our most recent publication in International Journal of Pharmaceutics! (October 30, 2019)
  • Congratulations to Wei-Chung Luo for receiving the Dr. Thomas Jennings Award at the 2019
    International Society Lyophilization-Freeze Drying East Coast Chapter Meeting! (September 19, 2019)
  • Check out our most recent publication in Nanotheranostics on overcoming hypoxia-induced chemoresistance with open access! (May 29, 2019)
  • Our new publication has been featured at UConn Today: Research Holds Promise for Improved Treatment of Ovarian Cancer (May 16, 2019)!                                                                                     ...  More

Contact Us

Phone: (860)486-5188
xiuling.lu@uconn.edu
Address: School of Pharmacy
University of Connecticut
69 North Eagleville Road
Unit 3092
Storrs, CT 06269-3092

Last updated on: 09/01/2020